Table 3.
Demographic data, tumor grade, and receptor status of the breast cancer patients, investigated during this study.
Average age (years) | Tumor grade (number of patients) | ER status (number of patients) | PR status (number of patients) | HER2 status (number of patients) | |
---|---|---|---|---|---|
Cancer patients | Group 1: <48 = 72 Group 2: >48 = 71 |
I = 18 II = 71 III = 45 IV = 9 |
ER+ = 55 ER− = 88 |
PR+ = 59 PR− = 84 |
HER2+ = 71 HER2− = 69 |